Compare FPF & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FPF | AORT |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 946.2M | 946.5M |
| IPO Year | 2013 | 1996 |
| Metric | FPF | AORT |
|---|---|---|
| Price | $15.63 | $19.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $38.47 |
| AVG Volume (30 Days) | 300.4K | ★ 713.0K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | ★ 8.08% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $10.91 |
| Revenue Next Year | N/A | $11.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $15.11 | $19.16 |
| 52 Week High | $19.36 | $48.25 |
| Indicator | FPF | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 34.84 |
| Support Level | $15.21 | N/A |
| Resistance Level | $15.99 | $24.74 |
| Average True Range (ATR) | 0.27 | 1.43 |
| MACD | 0.03 | -0.46 |
| Stochastic Oscillator | 52.06 | 1.37 |
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.